retatrutide clinical trial data Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA retatrutide clinical trial data done!

One large electronic database study showed there was a significantly increased risk of diabetic macular edema following GLP-1RA initiation compared to sodium-glucose cotransporter 2 inhibitors (SGLT2i)

Not to count calories, but to answer the questions that actually matter: Are you eating enough protein

For homeostatic feeding assessment using SD, mice were fasted overnight, whereas for hedonic feeding assessment (HFD), mice had ad libitum access to standard chow before testing

You might get somewhere, but you will not know if you are on course

And I don't say that to be like, dun, dun, dun

Gastrointestinal side effects may compound with both drugs